Semaglutide vs. Liraglutide: Generations of GLP-1 Peptide Therapy Compared
Medical Review by Dr. Sarah Jenkins, MD, Board-Certified Gastroenterologist • Updated 2026-10-28
Semaglutide represents a superior second-generation GLP-1 molecule compared to first-generation Liraglutide. In the STEP-8 randomized clinical trial, Semaglutide 2.4mg once-weekly delivered 15.8% average weight reduction compared to only 6.4% on Liraglutide 3.0mg once-daily, with superior adherence and fewer needle injections.
Liraglutide was the first GLP-1 agonist approved for chronic weight management (Saxenda in 2014) requiring daily subcutaneous injections due to its 13-hour half-life. Semaglutide was engineered with a C18 di-acid fatty chain spacer, extending albumin binding and pharmacokinetic half-life to 168 hours (7 days), resulting in more stable steady-state plasma concentrations.
Semaglutide (Ozempic/Wegovy)
15.8% weight loss, once-weekly injection, superior appetite control
Liraglutide (Saxenda/Victoza)
Short half-life clears within 24 hours if severe vomiting occurs
Head-to-Head Specification Matrix
| Parameter | Semaglutide (Ozempic/Wegovy) | Liraglutide (Saxenda/Victoza) | Clinical Impact |
|---|---|---|---|
| Mean Weight Loss at 68 Weeks (STEP-8 Trial) | 15.8% total body weight reduction | 6.4% total body weight reduction | Semaglutide produced more than double the weight reduction of daily Liraglutide. |
| Injection Frequency | Once per week (52 injections/year) | Once per day (365 injections/year) | Weekly administration dramatically improves patient compliance and adherence. |
| Pharmacokinetic Half-Life | 168 hours (7 days) | 13 hours | Liraglutides short half-life allows quick recovery from acute gastroparesis flares. |
| Generic Patent Availability | Patented until 2031+ in major markets | Patent expired; generic Victoza/Liraglutide available | Generic Liraglutide offers lower pricing for uninsured patients. |
GLP-1 Titration Dose Converter
Safely convert between daily Liraglutide (Saxenda) and weekly Semaglutide (Wegovy).
Frequently Asked Clinical Questions (FAQ)
Can you switch directly from daily Saxenda to weekly Wegovy?
Yes. Because Liraglutide clears within 24–48 hours, patients typically administer their final daily Saxenda dose, then initiate Semaglutide 0.5mg or 1.0mg the following day under physician supervision.
Why did Semaglutide replace Liraglutide in clinical practice?
Head-to-head clinical trials (STEP-8) demonstrated that Semaglutide delivered more than double the weight loss of Liraglutide (15.8% vs 6.4%) with greater convenience (once-weekly vs once-daily needle sticks).
Is nausea worse on Saxenda or Wegovy?
Initial nausea rates are comparable (~40%). However, if a patient experiences severe emesis on Saxenda, pausing the drug brings relief within 24 hours due to its 13-hour half-life, whereas Semaglutide remains active in the body for up to 5 weeks.